Lehr Martin A.

CIK 00018619891 companyPHILADELPHIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001861989

Recent Transactions

29 trades

Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2026-02-19+815,000→ 815,000 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2025-06-09$0.70/sh+100,000→ 920,190 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2025-02-13+802,700→ 802,700 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2024-03-21+291,402→ 291,402 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2023-02-21$0.84/sh+5,823→ 159,701 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2023-02-13+287,544→ 287,544 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2023-02-13$0.87/sh+5,606→ 153,878 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2023-02-06$0.97/sh+5,040→ 148,272 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2023-01-30$0.70/sh+7,027→ 143,232 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2023-01-23$0.72/sh+6,839→ 136,205 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2023-01-17$0.74/sh+6,783→ 129,366 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2022-12-16$0.74/sh+20,000→ 122,583 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2022-08-19$1.85/sh+13,000→ 102,583 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2022-02-25+254,300→ 254,300 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2021-12-16$3.22/sh+13,000→ 820,190 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22$5.00/sh+10,000→ 99,583 total
Exercise Out-of-Money
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22$7.14/sh+52,680→ 52,680 total
Conversion
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22+210,722→ 263,402 total
Conversion
Context Therapeutics Inc.$CNTX
Series Seed Preferred Stock
2021-10-22−586,475→ 1 total
Purchase
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22$5.00/sh+10,000→ 807,190 total
Exercise Out-of-Money
Context Therapeutics Inc.$CNTX
Warrant (right to buy)
2021-10-22+52,680→ 0 total
Exercise Out-of-Money
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22$7.14/sh+52,680→ 0 total
Conversion
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22+210,715→ 210,715 total
Conversion
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22+586,475→ 797,190 total
Conversion
Context Therapeutics Inc.$CNTX
Series A Preferred Stock
2021-10-22−210,715→ 7 total
Conversion
Context Therapeutics Inc.$CNTX
Series A Preferred Stock
2021-10-22−210,722→ 0 total
Exercise Out-of-Money
Context Therapeutics Inc.$CNTX
Warrant (right to buy)
2021-10-22+52,680→ 0 total
Conversion
Context Therapeutics Inc.$CNTX
Series Seed Preferred Stock
2021-10-22−586,476→ 0 total
Conversion
Context Therapeutics Inc.$CNTX
Common Stock
2021-10-22+586,476→ 849,878 total

Companies

Context Therapeutics Inc.
Director, Chief Executive Officer
$CNTX

Recent Filings

Address

2001 MARKET STREET SUITE 3915, UNIT #15

PHILADELPHIA, PA, 19103

View on SEC.gov